We are live on ! Find out more
PTLA

Portola Pharmaceuticals, Inc.
PTLA

Delisted

PTLA was delisted on the 1st of July, 2020.

Back to rankings

133 hedge funds and large institutions have $1.26B invested in Portola Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 19 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 12

168% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 19

68% more call options, than puts

Call options by funds: $962K | Put options by funds: $572K

34% more capital invested

Capital invested by funds: $938M → $1.26B (+$322M)

23% more funds holding

Funds holding: 108 → 133 (+25)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
133
Holders Change
+25
Holders Change %
+23.15%
% of All Funds
3.55%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
39
Increased
51
Reduced
19
Closed
12
Calls
$962K
Puts
$572K
Net Calls
+$390K
Net Calls Change
+$81K

Top Buyers

Rank Fund Capital Flow
1
Temasek Holdings
Temasek Holdings
Singapore
+$44.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.4M
3
SCM
Scopia Capital Management
New York
+$28.7M
4
State Street
State Street
Massachusetts
+$19.2M
5
Citadel Advisors
Citadel Advisors
Florida
+$16.8M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$8.12M
2
JP Morgan Chase
JP Morgan Chase
New York
-$4.32M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.04M
4
EAM
EverPoint Asset Management
Connecticut
-$3.79M
5
Millennium Management
Millennium Management
New York
-$3.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
26
Eventide Asset Management
Massachusetts
$10.5M – – –
Millennium Management
27
Millennium Management
New York
$10.3M -$3.17M -113,985 -24%
EMFAT
28
Emerald Mutual Fund Advisers Trust
Pennsylvania
$9.55M +$1.47M +52,972 +19%
AllianceBernstein
29
AllianceBernstein
Tennessee
$9.26M – – –
Geode Capital Management
30
Geode Capital Management
Massachusetts
$8.62M +$1.07M +38,611 +15%
Wells Fargo
31
Wells Fargo
California
$8.23M +$1.26M +45,338 +18%
Axa
32
Axa
France
$6.81M -$517K -18,613 -7%
FIM
33
Fernwood Investment Management
Massachusetts
$6.71M -$83.4K -3,000 -1%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$6.34M -$168K -6,027 -3%
BCM
35
BBT Capital Management
Texas
$5.66M – – –
TCIM
36
TIAA CREF Investment Management
New York
$5.66M +$280K +10,057 +5%
PI
37
Putnam Investments
Massachusetts
$5.65M – – –
PAMU
38
Pictet Asset Management (UK)
United Kingdom
$4.62M +$2.09M +75,272 +86%
Deutsche Bank
39
Deutsche Bank
Germany
$4.54M -$837K -30,121 -16%
GTC
40
Ghost Tree Capital
New York
$4.25M +$973K +35,000 +30%
GC
41
Guggenheim Capital
Illinois
$3.88M +$3.81M +136,999 New
HCM
42
Harvey Capital Management
Florida
$3.87M +$823K +29,600 +28%
BIM
43
BlackRock Investment Management
Delaware
$3.29M +$426K +15,321 +15%
Morgan Stanley
44
Morgan Stanley
New York
$3.19M +$1.61M +57,857 +106%
Charles Schwab
45
Charles Schwab
California
$3.13M +$543K +19,535 +21%
LOAMU
46
Lombard Odier Asset Management (USA)
New York
$2.9M +$2.85M +102,488 New
MAA
47
Managed Account Advisors
New Jersey
$2.55M -$190K -6,849 -7%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$2.25M +$321K +11,537 +17%
MSA
49
Mason Street Advisors
Wisconsin
$2.21M – – –
MCM
50
Mazama Capital Management
Oregon
$1.99M +$1.23M +44,304 +170%
1
2
3 4 5

PTLA Hedge Fund Activity: Q4 2014 in Review

133 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q4 2014, worth a combined $1.26B — up 34% from $938M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new PTLA positions and 12 closed out — a net gain of 27 holders — while 51 added to existing stakes and 19 trimmed.

The largest buyer was Temasek Holdings, adding an estimated $44.5M. The largest seller was Sectoral Asset Management, cutting an estimated $8.12M.

  • 133 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q4 2014, up from 108 in Q3 2014.
  • Funds reported $1.26B of Portola Pharmaceuticals, Inc. stock for Q4 2014, up 34% quarter-over-quarter.
  • 39 funds opened new Portola Pharmaceuticals, Inc. positions in Q4 2014 and 12 closed out, a net change of +27 holders.
  • The largest Portola Pharmaceuticals, Inc. buyer in Q4 2014 was Temasek Holdings, an estimated $44.5M added.
  • The largest Portola Pharmaceuticals, Inc. seller in Q4 2014 was Sectoral Asset Management, an estimated $8.12M sold.

Based on aggregated 13F filings for Q4 2014.